How PGIM India's Rs 112 crore Healthcare Fund picks CDMO stocks to generate alpha
6 September 2026 Updated 6 September 2026Source: Economic Times 1 min read
Quick Summary
PGIM India's Healthcare Fund focuses on high-growth segments like Contract Development and Manufacturing Organizations (CDMO), specialty pharma, and hospitals. This strategy aims to generate alpha. The fund's performance has been notable.
Key Takeaways
- The fund focuses on high-growth segments like CDMO, specialty pharma, and hospitals.
- The strategy aims to generate alpha.
- The fund's performance has been notable.
- The article mentions navigating hospital capacity expansions, China-plus-one opportunities, GLP-1 dynamics, and key stock-selection strategies.
Why It Matters
Understanding how funds like PGIM India's Healthcare Fund invest in high-growth segments can help retail investors make informed decisions about their own portfolios. This knowledge can also provide insights into the broader healthcare sector.
Summary, takeaways and analysis above are written by CAPITA1's AI from the source report. For educational purposes only. Not investment advice.